Login to Your Account

Virionhealth ‘DIps’ into Abingworth’s pockets with $17M series A round

By Cormac Sheridan
Staff Writer

Thursday, October 12, 2017

DUBLIN – Virionhealth Ltd., a newly funded U.K. startup, raised up to £13 million in series A funding to take forward a novel approach for preventing and treating respiratory viral infections, which relies on a long-recognized quirk of viral replication that has long been overlooked by the biotechnology industry.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription